Ipamorelin, the first selective growth hormone secretagogue European Journal of Endocrinology publishes this study on Ipamorelin, highlighting its selective action as a growth hormone secretagogue
The progression of T2D is driven not only by -cell dysfunction but also by intrinsic vulnerability factors within pancreatic cells themselves, manifested in transcriptomic alterations, as well as complex intercellular interactions involving immune, ductal, acinar, and stromal cells of the pancreas
GM Dysbiosis and Mechanisms Linking Obesity, MS, and T2D GM dysbiosis contributes to the development and progression of obesity, MS, and T2D through disruption of microbial functions essential for metabolic homeostasis
If you're tolerating treatment well, the escalation can proceed as planned
Targeting both pathways may give tirzepatide a broader effect on appetite and metabolism